Csenge Advisory Group Moderna, Inc. Transaction History

Csenge Advisory Group

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $154,868 - $232,670	2,228 New	2,228 $221,000
Q1 2023 May 01, 2023	BUY	$135.66 - $197.02 $92,384 - $134,170	681 Added 57.86%	1,858 $285,000
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $139,333 - $247,217	1,177 New	1,177 $211,000
Q2 2022 Jul 27, 2022	SELL	$117.13 - $176.59 $152,854 - $230,449	-1,305 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$126.46 - $235.05 $48,307 - $89,789	382 Added 41.39%	1,305 $225,000
Q4 2021 Feb 10, 2022	BUY	$225.82 - $368.51 $23,259 - $37,956	103 Added 12.56%	923 $217,000
Q3 2021 Oct 20, 2021	SELL	$221.9 - $484.47 $22,855 - $49,900	-103 Reduced 11.16%	820 $280,000
Q2 2021 Jul 21, 2021	BUY	$129.91 - $234.98 $119,906 - $216,886	923 New	923 $217,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

Stay updated on Csenge Advisory Group with notifications on news.